Spoiler Alert: No, unfortunately, they probably aren’t. In the standard medical model, physicians order routine lab tests primarily to help them make acute clinical decisions. This means standard labs are used to screen for full-blown diseases—like type 2 diabetes or cancer—or to diagnose conditions that have already manifested. They are used to help providers decide when to prescribe a medication, change a dosage, or write a referral to a specialist.
While this is useful information, it is a fundamentally reactive approach. There is so much more that can be accomplished with a proactive mindset. Today’s healthcare providers know far too much about the root contributors to chronic disease to settle for superficial, insensitive testing. True preventive medicine requires looking under the hood before the engine breaks down.
Of course, this can be a slippery slope. There are thousands of biomarkers available, and because patients do not have unlimited finances, we must be strategic. If we are aiming for the highest return on investment for your health and longevity, the two most critical areas to track using advanced lab testing are metabolic health and cardiovascular risk factors.
Cardiac is Still King
When we say “cardiac is king,” we mean that heart disease remains the undisputed, number-one cause of death in America, followed closely by cancer, unintentional falls, and stroke [1].
A crucial concept to grasp is that cardiovascular disease (CVD) is not an acute event; it is a chronic condition that begins in adolescence and quietly accumulates over the course of your lifetime. The amount of arterial damage you accumulate is a complex combination of your genetics, your environment, your metabolic health, and your lifestyle.
To truly assess your risk, a standard lipid panel (which simply measures Total Cholesterol, HDL, LDL, and Triglycerides) is no longer sufficient. We must look deeper into particle size, particle number, inflammatory markers, and metabolic hormones.
Here is a breakdown of the comprehensive markers that paint a true picture of your cardiovascular and metabolic health.
Part I: The Foundations of Metabolic Health
Before examining the cholesterol in your arteries, we must evaluate the metabolic environment of your blood. Poor metabolic health drives the inflammation and oxidation that make cholesterol dangerous in the first place.
Fasting Insulin
While most doctors check your Fasting Glucose or Hemoglobin A1c to screen for diabetes, these are late-stage markers. Fasting Insulin is the ultimate early-warning system. Decades before your blood sugar begins to rise, your pancreas will pump out increasing amounts of insulin to force glucose into your increasingly resistant cells [2]. High fasting insulin is a hallmark of insulin resistance, which is a primary driver of weight gain, metabolic syndrome, and eventual type 2 diabetes.
Triglycerides and the TC/HDL Ratio
Triglycerides are the most common type of fat in your body, storing excess energy from your diet. High triglycerides are strongly associated with insulin resistance and a diet high in refined carbohydrates and sugars.
When we look at your Total Cholesterol to HDL ratio (TC/HDL), or your Triglyceride to HDL ratio, we get a highly accurate proxy for your cardiovascular risk. A high ratio indicates that your metabolism is struggling to process fats and sugars efficiently, creating a highly atherogenic (plaque-building) environment [3].
Homocysteine
Homocysteine is a common amino acid in your blood that you get mostly from eating meat. However, high levels of it are linked to early development of heart disease. When your body lacks certain B vitamins (like B6, B12, and folate) or if you have a genetic MTHFR mutation, homocysteine can accumulate. Elevated homocysteine acts like microscopic sandpaper, scratching the delicate inner lining of your blood vessels (the endothelium) and initiating the plaque formation process [4].
25-OH Vitamin D
Vitamin D is not just a vitamin; it is a powerful prohormone that regulates hundreds of genes in your body. Beyond bone health, optimal Vitamin D levels are crucial for a balanced immune system and healthy endothelial function. Deficiency is strongly linked to hypertension, heart failure, and an increased risk of ischemic stroke [5].
Part II: Beyond the Basic Lipid Panel
A standard lipid panel measures the weight or concentration of cholesterol inside your lipoprotein particles. But modern lipidology tells us that the number and size of the particles matter much more.
Total Cholesterol, LDL, and HDL
Total Cholesterol: The total amount of cholesterol in your blood. By itself, this is a poor predictor of heart disease.
LDL-C (Low-Density Lipoprotein): Traditionally known as “bad” cholesterol. While high levels are a risk factor, standard tests only measure the cholesterol content, not the particles themselves.
HDL-C (High-Density Lipoprotein): Known as “good” cholesterol because HDL particles act like garbage trucks, pulling excess cholesterol away from the artery walls and returning it to the liver.
sdLDL (Small Dense LDL)
Not all LDL particles are created equal. Imagine your blood vessels are like a tennis net. If your LDL particles are large and buoyant (like beach balls), they bounce off the net and stay in the bloodstream where they belong. However, if your LDL particles are small and dense (sdLDL—like golf balls), they easily slip through the net and lodge themselves into your artery walls. Once inside the arterial wall, they oxidize and trigger plaque formation. Measuring sdLDL tells us how dangerous your cholesterol actually is.
Lp(a) – Lipoprotein(a)
Often referred to as the “widow-maker” biomarker, Lipoprotein(a) is a highly genetic variant of an LDL particle. It is essentially an LDL particle with a sticky protein attached to it, making it highly prone to causing blood clots and aggressively driving plaque buildup. Because Lp(a) levels are determined by your genetics, they do not respond significantly to diet or exercise [6]. Testing for it at least once in your life is vital to understanding your baseline genetic risk.
Part III: The Ultimate Particle Counts (ApoB & ApoA-I)
If you truly want to know your cardiovascular risk, measuring Apolipoproteins is the gold standard of modern preventative cardiology.
Apolipoprotein B (ApoB)
Apolipoprotein B (ApoB) is a protein found in the blood that acts as the primary structural component of all atherogenic (plaque-causing) lipoproteins, including LDL, VLDL, and Lp(a).
Think of ApoB as a tag: there is exactly one ApoB protein attached to every single “bad” cholesterol particle. Therefore, measuring ApoB gives us the exact headcount of dangerous particles circulating in your bloodstream, rather than just guessing based on the total weight of the cholesterol.
ApoB is deeply involved in transporting lipids to tissues, but high levels mean a traffic jam in your arteries. LDL cholesterol can build up, leading to plaque formation and atherosclerosis, which restricts blood flow to the heart and brain. Standard medicine relies on LDL-C, but leading cardiologists now recognize ApoB as a far superior predictor of cardiovascular events [7].
Factors that increase ApoB:
High triglycerides and total cholesterol
Obesity and Type 2 Diabetes
Insulin resistance
Smoking
A family history of early heart disease
How to lower ApoB:
Transitioning to a whole-foods, low-processed-sugar diet
Consistent cardiovascular and resistance exercise
Losing visceral body fat
Quitting smoking
Taking targeted medications (like statins or PCSK9 inhibitors) under a doctor’s care
Apolipoprotein A-I (ApoA-I)
Apolipoprotein A-I (ApoA-I) is the essential structural protein for high-density lipoprotein (HDL), the “good” cholesterol. If ApoB represents the plaque-building particles, ApoA-I represents the plaque-clearing particles.
ApoA-I binds to cholesterol in your tissues and artery walls and helps transport it back to the liver for excretion—a process known as reverse cholesterol transport. Beyond transport, ApoA-I is highly protective. It helps regulate inflammation and actively protects against the development of heart disease. Low levels of ApoA-I indicate that your body lacks the “garbage trucks” needed to clear out arterial waste, increasing your risk of cardiovascular events [8].
How to improve ApoA-I levels:
Consuming a diet rich in healthy fats (olive oil, avocados, omega-3s)
Engaging in regular aerobic exercise
Avoiding trans fats and heavily processed seed oils
Discussing advanced lipid-modulating therapies with your provider
Part IV: The Fire Inside — Measuring Inflammation
You can have high cholesterol and a high particle count, but if you do not have inflammation, those particles are much less likely to stick to your artery walls. Inflammation is the fire that drives cardiovascular disease.
hs-CRP (High-Sensitivity C-Reactive Protein)
C-reactive protein (CRP) is a protein produced by the liver in response to systemic inflammation. While a standard CRP test looks for massive inflammation (like from an acute infection or autoimmune flare-up), a high-sensitivity CRP (hs-CRP) test is designed to detect micro-levels of chronic, smoldering inflammation.
Chronic inflammation is a silent killer. It damages the endothelium and makes cholesterol sticky, dramatically increasing your risk for heart disease, strokes, and neurodegenerative conditions [9].
An hs-CRP test is highly recommended if you have:
A family history of heart disease
Other risk factors like high blood pressure, elevated ApoB, or diabetes
Symptoms like chest pain, chronic fatigue, or joint pain
Note on hs-CRP: This is not a diagnostic test. A high hs-CRP doesn’t tell you where the inflammation is coming from (it could be from a gut infection, poor sleep, or arterial plaque). However, it tells us that a fire is burning, and we need to extinguish it. If your hs-CRP is elevated, your doctor will likely recommend targeted lifestyle interventions—such as an anti-inflammatory diet, weight loss, and stress reduction—to lower your risk.
Lp-PLA2 (The PLAC Test)
While hs-CRP measures general, whole-body inflammation, Lp-PLA2 (lipoprotein-associated phospholipase A2) measures inflammation specifically inside your blood vessels.
Lp-PLA2 is an enzyme produced by macrophages (immune cells) inside the arterial wall. When plaque builds up in your arteries, macrophages rush in to clean it up. If they become overwhelmed, they secrete Lp-PLA2. High levels of this enzyme indicate that the plaque inside your arteries is inflamed, unstable, and vulnerable to rupturing.
It is vital to understand that most heart attacks are not caused by a slow, gradual clogging of a pipe. They are caused by an inflamed plaque rupturing, which triggers a sudden blood clot that stops blood flow. Lp-PLA2 is a direct marker for this rupture risk [10].
Factors increasing Lp-PLA2:
Smoking
High blood pressure
Elevated ApoB and oxidized LDL
Obesity and underlying infections
How to lower Lp-PLA2:
Aggressive blood pressure and cholesterol management
Quitting smoking entirely
Resolving underlying inflammatory issues (like periodontal disease or gut dysbiosis)
Prioritizing regular physical activity and a nutrient-dense diet
Take Control of Your Baseline
Standard medicine waits for you to become a patient. Functional, advanced testing empowers you to remain a healthy person. By shifting your focus from standard, superficial panels to deep, comprehensive markers of cardiovascular risk and metabolic function, you take control of the steering wheel.
You don’t have to guess about your heart health. The data is available, and it is more accessible than ever before.
If you are ready to look past the standard reference ranges and get a true, unfiltered look at your metabolic and cardiovascular health, you can order your advanced lab testing panels directly through our portal.
Order your comprehensive cardiovascular and metabolic lab panel today: Access the Rupa Health Storefront Here
References
Centers for Disease Control and Prevention. (2023). Leading Causes of Death. National Center for Health Statistics.
Kraft, J. R. (1975). Detection of diabetes mellitus in situ (occult diabetes). Laboratory Medicine, 6(2), 10-22.
McLaughlin, T., et al. (2005). Usefulness of identifying testing for insulin resistance. American Journal of Cardiology, 96(3), 399-404.
Ganguly, P., & Alam, S. F. (2015). Role of homocysteine in the development of cardiovascular disease. Nutrition Journal, 14, 6.
Judd, S. E., & Tangpricha, V. (2009). Vitamin D deficiency and risk for cardiovascular disease. The American Journal of the Medical Sciences, 338(1), 40-44.
Tsimikas, S. (2017). A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. Journal of the American College of Cardiology, 69(6), 692-711.
Sniderman, A. D., et al. (2011). A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes, 4(3), 337-345.
Asztalos, B. F., et al. (2004). Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events. The American Journal of Cardiology, 93(9), 1088-1092.
Ridker, P. M., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER Trial). The New England Journal of Medicine, 359(21), 2195-2207.
Thompson, A., et al. (2010). Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. The Lancet, 375(9725), 1536-1544.
